Karina A. Pasquevich

发表

Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis.

P. Mathieu, F. Pitossi, M. Delpino, 2010, The American journal of pathology.

Brucella abortus Inhibits Major Histocompatibility Complex Class II Expression and Antigen Processing through Interleukin-6 Secretion via Toll-Like Receptor 2

M. Delpino, C. A. Fossati, G. Giambartolomei, 2007, Infection and Immunity.

An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice

Fernanda S. Oliveira, S. Oliveira, H. Warzecha, 2011, PloS one.

A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.

D. Laplagne, F. Goldbaum, S. Estein, 2007, Vaccine.

A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.

D. Laplagne, F. Goldbaum, S. Estein, 2007, Vaccine.

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

S. Estein, C. A. Fossati, G. Giambartolomei, 2008, Infection and Immunity.

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System

D. Comerci, Francisco Guaimas, J. Cassataro, 2019, Front. Immunol..

The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis

Fernanda S. Oliveira, J. Borkowski, S. Oliveira, 2010, The Journal of Immunology.

Systemic bacterial infections affect dendritic cell development and function.

Karina A. Pasquevich, K. Bieber, S. Autenrieth, 2021, International journal of medical microbiology : IJMM.

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice

S. McSorley, G. Briones, Seung‐Joo Lee, 2017, Front. Immunol..

RomA, A Periplasmic Protein Involved in the Synthesis of the Lipopolysaccharide, Tunes Down the Inflammatory Response Triggered by Brucella

C. Czibener, Juan E Ugalde, S. Altabe, 2018, The Journal of infectious diseases.

Innate immune system favors emergency monopoiesis at the expense of DC‐differentiation to control systemic bacterial infection in mice

C. Lengerke, H. Rammensee, L. Zender, 2015, European journal of immunology.

A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection

Lucía B. Chemes, D. Alvarez, Julieta Alcain, 2021, bioRxiv.

Sublingual Omp16‐driven redirection of the allergic intestinal response in a pre‐clinical model of food allergy

C. A. Fossati, J. Cassataro, Karina A. Pasquevich, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses

M. Tkach, R. Schillaci, A. Trevani, 2016, The Journal of Immunology.

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier

Francisco Guaimas, J. Cassataro, Karina A. Pasquevich, 2019, Journal of controlled release : official journal of the Controlled Release Society.

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19

Lucía B. Chemes, Rodolfo M. Rasia, J. Cassataro, 2022, Computational and structural biotechnology journal.

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge

J. Cassataro, Karina A. Pasquevich, Lorena M. Coria, 2020, Vaccine.

Antibody Reactivity to Omp31 from Brucella melitensis in Human and Animal Infections by Smooth and Rough Brucellae

C. A. Fossati, P. Baldi, J. Cassataro, 2004, Clinical Diagnostic Laboratory Immunology.

Stability Studies of the Vaccine Adjuvant U-Omp19

J. Cassataro, Karina A. Pasquevich, Laura A. Bruno, 2020, Journal of pharmaceutical sciences.

Brucella abortus activates human neutrophils.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2009, Microbes and infection.